Skoog Jessica, Midlöv Patrik, Beckman Anders, Sundquist Jan, Halling Anders
Department of Clinical Sciences in Malmö, Center for Primary Health Care Research, Lund University, SE-205 02, Malmö, Sweden.
Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA.
BMC Geriatr. 2015 Oct 8;15:117. doi: 10.1186/s12877-015-0117-x.
Although the elderly have a substantially higher drug use than younger patients, even after adjustment for multimorbidity, there is limited knowledge about the elderly's indication for treatment. It is essential for elderly patients to have a well-planned drug therapy. The first step towards a correct and safe drug therapy is to ensure that the patient's drugs have an indication, i.e. correct diagnoses are linked to all of the prescription drugs. The aim of this study was to examine to what extent elderly patients have indication for a number of their prescribed drugs and, furthermore, if there are any differences in indication for treatment depending on gender, age, level of multimorbidity and income.
Data were collected on individuals aged 65 years or older in Östergötland County in Sweden. To estimate the individual level of multimorbidity the Johns Hopkins ACG Case-Mix System was used. A report from the Swedish National Board of Health and Welfare was used to identify prescription drugs, for which it is important to have a correct diagnosis. The proportions of patients having indication for these prescription drugs were calculated. Odds ratios of having indication for treatment depending on gender, age, multimorbidity level and income were calculated.
On average 45.1 % (range 12.9 % - 75.8 %) of the patients' prescribed drugs had indication. Proton pump inhibitors were associated with the lowest level of indication (12.9 %) and digoxin was associated with the highest level of indication for treatment (75.8 %). Patients aged 80 years or older had the lowest odds ratios of having indication for treatment.
On average, there was indication for treatment in less than half of the prescription drugs studied. The quality was highest in relation to multimorbidity and lowest in relation to age. The result may to some extent be explained by substandard registration of diagnoses. Since lack of quality of prescription drug use is highly associated with inconvenience among the elderly, as well as high costs to society, it is important that future research and allocation of resources focus on the quality of elderly patients' drug therapy.
尽管老年人的用药量比年轻患者高得多,即便在对多种疾病进行调整之后,关于老年人的治疗指征仍知之甚少。对老年患者而言,进行精心规划的药物治疗至关重要。实现正确且安全的药物治疗的第一步是确保患者所服用的药物有治疗指征,即正确的诊断与所有处方药相关联。本研究的目的是调查老年患者所服用的多种处方药有治疗指征的程度,此外,探究治疗指征是否因性别、年龄、多种疾病程度和收入而存在差异。
收集了瑞典东约特兰省65岁及以上人群的数据。使用约翰霍普金斯ACG病例组合系统来评估个体的多种疾病水平。利用瑞典国家卫生与福利委员会的一份报告来确定那些需要正确诊断的处方药。计算了有这些处方药治疗指征的患者比例。计算了根据性别、年龄、多种疾病程度和收入有治疗指征的比值比。
患者所服用的处方药平均有45.1%(范围为12.9% - 75.8%)有治疗指征。质子泵抑制剂的治疗指征水平最低(12.9%),地高辛的治疗指征水平最高(75.8%)。80岁及以上的患者有治疗指征的比值比最低。
在所研究的处方药中,平均不到一半有治疗指征。与多种疾病相关的质量最高,与年龄相关的质量最低。该结果在一定程度上可能是由于诊断记录不规范所致。由于处方药使用质量欠佳与老年人的不便以及社会的高成本密切相关,未来的研究和资源分配应聚焦于老年患者药物治疗的质量,这一点很重要。